Kenning
Not started
Quick win kit · 7 days · yours forever

Nobody asks about this one.
So we will.

Constipation is one of the most common effects of these medications and one of the least discussed, because it is the symptom women are least willing to raise out loud. It also has at least six different causes, and the fix for one of them makes another worse. This kit works out which one is yours, gives you five days aimed at it, watches for the small number of signs that mean stop, and then tells you plainly whether it worked.

Eight question read Five day protocol Daily safety check A page for your prescriber Reusable at every dose increase
ONE

First, which kind is this?

Slow transit and difficulty emptying are two different problems that feel similar and need opposite things. Fiber helps one and makes the other worse. So before a single instruction, we work out which one you have.

FOUR

When this is not ordinary constipation

Read this once now, before you need it. Most constipation on these medications is uncomfortable and manageable. A small number of presentations are not, and with a medication that slows the gut they are worth knowing by name. The kit checks for these every day, so remembering is not your job alone.

Contact your prescriber today, or go to urgent care, if you have

  • No bowel movement for four days or more together with vomiting
  • A swollen, hard, tender stomach, particularly if you cannot pass gas at all
  • Severe stomach pain that keeps getting worse rather than easing
  • Blood in the stool, or stool that is black and tarry
  • Vomiting that will not stop, or vomiting up what you ate many hours earlier
These can indicate the gut has stopped moving rather than simply slowed. That needs examining today, not managing at home. Bring the summary page this kit makes for you.
Clinical content pending PharmD review · sources cited

If this happens again

You will not be starting over. When it comes back, most often at your next dose increase:

  1. Reopen this kit.
  2. Your previous plan is already saved.
  3. Compare what you are feeling now against your last episode.
  4. Change one thing at a time, so you learn something.
References
  1. Constipation affects roughly 7 to 12 percent of patients in pooled trial data, with substantially higher figures reported in real world cohorts. Gastrointestinal effects overall are common and vary widely by drug and dose.
  2. These medications slow gastric emptying and intestinal transit as a core mechanism, so reduced bowel frequency is an expected effect rather than an unexpected one.
  3. Gastrointestinal symptoms are dose dependent and concentrate in the first weeks of treatment and at each dose increase.
  4. Fiber with adequate fluid is a reasonable first approach for ordinary constipation. It works far less well where transit is already slowed or where the difficulty is with emptying: in one comparison, patients with slow transit or pelvic floor dysfunction responded poorly to 30 grams of fiber daily while those without an underlying motility disorder improved.
  5. Where the difficulty is with emptying rather than transit, guidance recommends pelvic floor retraining by biofeedback therapy rather than laxatives, a strong recommendation supported by high quality evidence. Recent practice guidance estimates that around 37 percent of people with chronic constipation have a defecatory disorder, including many who also have slow transit.
  6. Pelvic floor function changes across the menopause transition, which is relevant to evacuation difficulty in this age group.
  7. Gastrointestinal symptoms are the most consistent self reported reason for stopping GLP-1 therapy.

Full citations in AMA format are pending final formatting alongside PharmD review.

Reviewed by Kenning's clinical and outcomes research team · educational only · not medical advice. Population specific thresholds pending PharmD review.